Value Investing Articles

Results 1 - 10 of 50 : 1 2 3 4 5 Next

July 31, 2015

What's Nike Inc.'s Secret Sauce?

A history of stellar management, a successful switch into direct-to-consumer sales, and strategically profitable investments in R&D and marketing are all traits that keep Nike ahead of the pack.

July 31, 2015

5 Key Points You May Have Missed in Merck's Q2 Report

Merck's Q2 results topped Wall Street's expectations, but its headline figures don't tell the full story.

July 31, 2015

3 Things You Likely Missed in Pfizer's Q2 Report

Pfizer knocked it out of the ballpark in Q2, but you probably missed these three important points if you were enamored with the headline figures.

July 27, 2015

3 Important Questions We Want Answered When Merck Reports Its Q2 Results

Big Pharma Merck is scheduled to report its second-quarter earnings results on July 28. Here are three questions investors are expecting to have answered on that date.

July 27, 2015

3 Questions Wall Street Wants Answered When Pfizer Reports Q2 Results

Big Pharma Pfizer is on deck with its Q2 earnings results. See what questions and concerns Wall Street and investors expect Pfizer to address.

July 21, 2015

The Best Deals in Value Stocks

It's true that the broad-based S&P 500 has more than tripled since March 2009, but there are still plenty of enticing value stocks worth considering if you're willing to do some digging.

July 19, 2015

7 Facts You Probably Don't Know About Big Pharma

Big Pharma companies are truly in a class of their own. Here are seven facts about the industry you may not be aware of.

July 15, 2015

3 Questions Johnson & Johnson's Second-Quarter Results Answered

Johnson & Johnson kicks off earnings season for the pharmaceutical sector and answers some very important questions and concerns in the process.

July 12, 2015

Exxonmobil: Value Play or Value Trap?

ExxonMobil has looked bleak for a while, and shares have plunged. Which begs the question, has the price fallen low enough to warrant plunging in for some deep value, or is Exxon more of a value trap?

May 28, 2015

Undervalued Stocks in Biotech Worth Buying

Even though the term "bubble" is being tossed around with regard to biotech stocks, there are still three undervalued stocks in the sector worth buying.

Results 1 - 10 of 50 : 1 2 3 4 5 Next


Advertisement